BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35945389)

  • 1. Percutaneous cryoablation combined with prior transcatheter arterial embolization for renal cell carcinomas of 3 cm or larger: a prospective study.
    Gobara H; Matsui Y; Uka M; Tomita K; Umakoshi N; Araki M; Sakurai J; Iguchi T; Hiraki T
    Int J Clin Oncol; 2022 Oct; 27(10):1589-1595. PubMed ID: 35945389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cryoablation combined with prior transcatheter arterial embolization in non-dialysis patients with stage 4 or 5 chronic kidney disease: a retrospective study.
    Umakoshi N; Iguchi T; Matsui Y; Tomita K; Uka M; Kawabata T; Munetomo K; Nagata S; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2023 Sep; 41(9):1007-1014. PubMed ID: 37002430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Arterial Embolization with a Mixture of Absolute Ethanol and Iodized Oil for Poorly Visualized Endophytic Renal Masses Prior to CT-Guided Percutaneous Cryoablation.
    Michimoto K; Shimizu K; Kameoka Y; Sadaoka S; Miki J; Kishimoto K
    Cardiovasc Intervent Radiol; 2016 Nov; 39(11):1589-1594. PubMed ID: 27380871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.
    Gobara H; Hiraki T; Iguchi T; Matsui Y; Sakurai J; Uka M; Tomita K; Komaki T; Kobayasi Y; Araki M; Watanabe T; Kanazawa S
    Int J Clin Oncol; 2021 Mar; 26(3):562-568. PubMed ID: 33174078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous cryoablation for clinical T3a renal cell carcinoma (< 7 cm) with segmental vein involvement or perinephric fat invasion based on preoperative evaluation of high-resolution multidetector computed tomography scan.
    Uka M; Iguchi T; Okawa N; Matsui Y; Tomita K; Umakoshi N; Munetomo K; Gobara H; Araki M; Hiraki T
    Jpn J Radiol; 2022 Nov; 40(11):1201-1209. PubMed ID: 35727459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous Cryoablation of Clinical T2 (> 7 cm) Renal Masses: Technical Considerations, Complications, and Short-Term Outcomes.
    Moynagh MR; Schmit GD; Thompson RH; Boorjian SA; Woodrum DA; Curry TB; Atwell TD
    J Vasc Interv Radiol; 2015 Jun; 26(6):800-6. PubMed ID: 25840835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial embolization of T1b and T2a renal cell carcinoma prior to percutaneous cryoablation: a retrospective comparative study.
    Salei A; Raymond M; Savage C; Huang J; Caridi TM; Rais-Bahrami S; Gunn AJ
    Abdom Radiol (NY); 2023 Feb; 48(2):773-779. PubMed ID: 36454278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?
    Aoun HD; Littrup PJ; Jaber M; Memon F; Adam B; Krycia M; Prus M; Heath E; Pontes E
    J Vasc Interv Radiol; 2017 Oct; 28(10):1363-1370. PubMed ID: 28844831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience.
    Atwell TD; Farrell MA; Callstrom MR; Charboneau JW; Leibovich BC; Patterson DE; Chow GK; Blute ML
    Radiology; 2007 Apr; 243(1):276-83. PubMed ID: 17329689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous CT- and MRI-guided Cryoablation of cT1 Renal Cell Carcinoma: Intermediate- to Long-term Outcomes in 307 Patients.
    Bhagavatula SK; Tuncali K; Shyn PB; Levesque VM; Chang SL; Silverman SG
    Radiology; 2020 Sep; 296(3):687-695. PubMed ID: 32633677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous cryoablation of renal masses >or=3 cm: efficacy and safety in treatment of 108 patients.
    Schmit GD; Atwell TD; Callstrom MR; Farrell MA; Leibovich BC; Patterson DE; Chow GK; Blute ML; Charboneau JW
    J Endourol; 2010 Aug; 24(8):1255-62. PubMed ID: 20380510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of CT-guided cryoablation after lipiodol marking and embolization for RCC.
    Kajiwara K; Yoshimatsu R; Komoto M; Maeda H; Yamanishi T; Minamiguchi H; Karashima T; Inoue K; Awai K; Yamagami T
    Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):923-929. PubMed ID: 35057706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study.
    Georgiades CS; Rodriguez R
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1494-9. PubMed ID: 24385225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Image-guided Cryoablation for Sporadic Renal Cell Carcinoma: Three- and 5-year Outcomes in 220 Patients with Biopsy-proven Renal Cell Carcinoma.
    Breen DJ; King AJ; Patel N; Lockyer R; Hayes M
    Radiology; 2018 Nov; 289(2):554-561. PubMed ID: 30084744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Renal Tumors Treated by Image-Guided Percutaneous Cryoablation: Immediate and 3- and 5-Year Outcomes at a Regional Center.
    Lim E; Kumar S; Seager M; Modi S; Mandal I; Neves JB; Jones S; Tran MGB; Munneke G; Bandula S; Walkden M
    AJR Am J Roentgenol; 2020 Jul; 215(1):242-247. PubMed ID: 32286877
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryoablation of renal cell carcinoma for patients with stage 4 or 5 non-dialysis chronic kidney disease.
    Gobara H; Nakatsuka A; Shimizu K; Yamanaka T; Matsui Y; Iguchi T; Hiraki T; Yamakado K
    Jpn J Radiol; 2019 Jun; 37(6):481-486. PubMed ID: 30941617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
    Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
    Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Cryoablation of Renal Cell Carcinoma with Sinus Vein Involvement Based on Preprocedural Imaging.
    Atwell TD; Kurup AN; Boorjian SA; Schmitz JJ; Thompson RH; Leibovich BC; Schmit GD
    J Vasc Interv Radiol; 2017 Dec; 28(12):1651-1657. PubMed ID: 29042169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.